44 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
in the Company’s group health care coverage programs, your coverage ends on the last day of the month in which the Separation Date occurs (the “Health Care Coverage … End Date”). You will have the right to continue group health care coverage in those programs after the Separation Date under the law known
8-K
EX-10.1
3hpb8y8bits482cc
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
y64qfqh bqoj4
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am